Two biotechs raise a combined $556M in latest spurt of IPOs
BioPharma Dive
Seaport Therapeutics and Hemab Therapeutics on Thursday became the latest drugmakers to debut on Wall Street, continuing a stretch of large IPOs this year that collectively raised almost $3.2 billion.
pharminent
May 1, 2026 (Last updated: May 1, 2026)
BioPharma Dive
Seaport Therapeutics and Hemab Therapeutics on Thursday became the latest drugmakers to debut on Wall Street, continuing a stretch of large IPOs this year that collectively raised almost $3.2 billion.